Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Antibody / Recombinant Antibody

Anti-ssRNA Antibody (JEL103)

Catalog #:   RGK25001 Specific References (50) DATASHEET
Host species: Mouse
Isotype: IgG2a, kappa
Applications: DB, ELISA
Overview

Catalog No.

RGK25001

Host species

Mouse

Isotype

IgG2a, kappa

Clonality

Monoclonal

Target

ssRNA, Single-stranded RNA

Concentration

2.6 mg/ml

Endotoxin level

Please contact with the lab for this information.

Purity

>95% as determined by SDS-PAGE.

Purification

Protein A/G purified from cell culture supernatant.

Applications

DB, ELISA

Form

Liquid

Storage buffer

0.01M PBS, pH 7.4.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term.

Clone ID

JEL103

Data Image
References

Base-pair resolution reveals clustered R-loops and DNA damage-susceptible R-loops., PMID:40112807

Two-Dimensional Nanozyme-Catalyzed Colorimetric CRISPR Assay for the Microfluidic Detection of Monkeypox Virus., PMID:39965890

Influenza A Vaccine Candidates Based on Virus-like Particles Formed by Coat Proteins of Single-Stranded RNA Phages Beihai32 and PQ465., PMID:39340063

CD4+ T cells reactive to a hybrid peptide from insulin-chromogranin A adopt a distinct effector fate and are pathogenic in autoimmune diabetes., PMID:39214091

Regulation of pulmonary plasma cell responses during secondary infection with influenza virus., PMID:38661717

Prediction of Prospective Mutational Landscape of SARS-CoV-2 Spike ssRNA and Evolutionary Basis of Its Host Interaction., PMID:38619800

Preclinical Evaluation of virus-like particle Vaccine Against Carbonic Anhydrase IX Efficacy in a Mouse Breast Cancer Model System., PMID:38217826

An RNA-Scaffold Protein Subunit Vaccine for Nasal Immunization., PMID:37896953

The vaccinia virus E3L dsRNA binding protein detects distinct production patterns of exogenous and endogenous dsRNA., PMID:37790463

Disease in the Pld4thss/thss Model of Murine Lupus Requires TLR9., PMID:37555846

B cell-intrinsic TLR7 signaling is required for neutralizing antibody responses to SARS-CoV-2 and pathogen-like COVID-19 vaccines., PMID:37438976

Thromboembolism in the Complications of Long COVID-19., PMID:37389402

Proof-of-concept for effective antiviral activity of an in silico designed decoy synthetic mRNA against SARS-CoV-2 in the Vero E6 cell-based infection model., PMID:37152730

Contribution of S100A4-expressing fibroblasts to anti-SSA/Ro-associated atrioventricular nodal calcification and soluble S100A4 as a biomarker of clinical severity., PMID:37090702

Identification of Orbivirus Non-Structural Protein 5 (NS5), Its Role and Interaction with RNA/DNA in Infected Cells., PMID:37047816

Visualization of RNA virus infection in a marine protist with a universal biomarker., PMID:37037845

Pseudotyped Viruses for Lyssavirus., PMID:36920698

Chemically modified aptamers for improving binding affinity to the target proteins via enhanced non-covalent bonding., PMID:36910146

Innate and Adaptive Immunity during SARS-CoV-2 Infection: Biomolecular Cellular Markers and Mechanisms., PMID:36851285

An Immunological Review of SARS-CoV-2 Infection and Vaccine Serology: Innate and Adaptive Responses to mRNA, Adenovirus, Inactivated and Protein Subunit Vaccines., PMID:36679897

Novel Flavi-like virus in ixodid ticks and patients in Russia., PMID:36529011

Oocytes could rearrange immunoglobulin production to survive over adverse environmental stimuli., PMID:36405746

Insight into genomic organization of pathogenic coronaviruses, SARS-CoV-2: Implication for emergence of new variants, laboratory diagnosis and treatment options., PMID:39157715

Single-stranded RNA adjuvant enhances the efficacy of 10-valent human papilloma virus-like particle vaccine., PMID:35979884

Development of a one-step RT-qPCR assay for the detection of Grapevine leafroll-associated virus 7., PMID:35820624

R-Loop Detection in Bacteria., PMID:35704183

Clinical and molecular aspects of human pegiviruses in the interaction host and infectious agent., PMID:35264187

Discovering potent inhibitors against the Mpro of the SARS-CoV-2. A medicinal chemistry approach., PMID:35123137

TIR-Domain-Containing Adapter-Inducing Interferon-β (TRIF)-Dependent Antiviral Responses Protect Mice against Ross River Virus Disease., PMID:35089088

Antiphospholipid antibody-induced trophoblast responses are differentially modulated by viral dsRNA and viral ssRNA., PMID:34904767

Cleavage of DNA and RNA by PLD3 and PLD4 limits autoinflammatory triggering by multiple sensors., PMID:34620855

Hydroxychloroquine inhibits proteolytic processing of endogenous TLR7 protein in human primary plasmacytoid dendritic cells., PMID:34580855

Case report: hepatitis in a child infected with SARS-CoV-2 presenting toll-like receptor 7 Gln11Leu single nucleotide polymorphism., PMID:34482844

Recombinant SARS-CoV-2 Nucleocapsid Protein: Expression, Purification, and Its Biochemical Characterization and Utility in Serological Assay Development to Assess Immunological Responses to SARS-CoV-2 Infection., PMID:34451501

Neutralization of MERS coronavirus through a scalable nanoparticle vaccine., PMID:34429427

TLR7 Activation of Macrophages by Imiquimod Inhibits HIV Infection through Modulation of Viral Entry Cellular Factors., PMID:34356516

Discovery and Characterization of a Novel Bipartite Botrexvirus From the Phytopathogenic Fungus Botryosphaeria dothidea., PMID:34276630

Effective inactivated influenza vaccine for the elderly using a single-stranded RNA-based adjuvant., PMID:34099809

Role of Structural and Non-Structural Proteins and Therapeutic Targets of SARS-CoV-2 for COVID-19., PMID:33917481

Current state of diagnostic, screening and surveillance testing methods for COVID-19 from an analytical chemistry point of view., PMID:33897053

TLR7 Is Critical for Anti-Viral Humoral Immunity to EV71 Infection in the Spinal Cord., PMID:33679702

Inflammation, immunity and potential target therapy of SARS-COV-2: A total scale analysis review., PMID:33640537

The impact of size on particle drainage dynamics and antibody response., PMID:33450322

Occurrence of Soybean Yellow Common Mosaic Virus in Soybean in China Showing Yellow Common Mosaic Disease., PMID:33200969

Deciphering the Role of Bovine Viral Diarrhea Virus Non-Structural NS4B Protein in Viral Pathogenesis., PMID:33142856

Progress in the Production of Virus-Like Particles for Vaccination against Hepatitis E Virus., PMID:32751441

Inactivated influenza vaccine formulated with single-stranded RNA-based adjuvant confers mucosal immunity and cross-protection against influenza virus infection., PMID:32739118

Novel ssRNA phage VLP platform for displaying foreign epitopes by genetic fusion., PMID:32713683

Nanoformulated Single-Stranded RNA-Based Adjuvant with a Coordinative Amphiphile as an Effective Stabilizer: Inducing Humoral Immune Response by Activation of Antigen-Presenting Cells., PMID:32239636

Double Crossed: A Case of La Crosse Encephalitis., PMID:32236166

Datasheet

Document Download

Anti-ssRNA Antibody (JEL103).pdf

 

$ 372
Product specifications
100 μg 372 1 mg 1860

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Anti-ssRNA Antibody (JEL103) [RGK25001]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2025 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only